Using human colon carcinoma HCT116 cells, esculetin was demonstrated to induce the hypoxia-inducible factor 1 alpha (HIF-1α), promote the secretion of vascular endothelial grown factor (VEGF), and inhibit HIF prolyl hydroxylases (PHD) activity [51]. The gene discussed is HIF1A; the disease is colon carcinoma.